Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Bionano Genomics, Inc. (BNGO) had Free Cash Flow per Share of $-1.82 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$6.73M |
|
$-6.86M |
|
$3.26M |
|
$3.48M |
|
$14.53M |
|
$-7.80M |
|
$0.95M |
|
$-6.85M |
|
$-6.85M |
|
$-6.86M |
|
$-6.86M |
|
$-6.86M |
|
$-6.86M |
|
$-7.80M |
|
$-5.62M |
|
3.44M |
|
3.44M |
|
$-1.99 |
|
$-1.99 |
|
| Balance Sheet Financials | |
$42.66M |
|
$17.26M |
|
$33.35M |
|
$76.01M |
|
$24.18M |
|
$3.51M |
|
$6.46M |
|
$30.64M |
|
$45.37M |
|
$38.35M |
|
$45.37M |
|
3.91M |
|
| Cash Flow Statement Financials | |
$-6.25M |
|
$-12.09M |
|
$12.36M |
|
$9.57M |
|
$3.56M |
|
$-6.01M |
|
$2.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.76 |
|
-- |
|
-- |
|
0.07 |
|
0.34 |
|
51.64% |
|
-115.85% |
|
-115.85% |
|
-- |
|
-101.69% |
|
-101.84% |
|
$-6.25M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.38 |
|
1.93 |
|
46.69 |
|
-15.11% |
|
-17.88% |
|
-9.02% |
|
-14.03% |
|
$11.61 |
|
|
Free Cash Flow per Share |
$-1.82 |
$-1.82 |
|